Gujarat Themis Biosyn pays final settlement amount of Rs 31.00 lakh to GIIC

03 Apr 2014 Evaluate

Gujarat Themis Biosyn has paid an amount of Rs 31.00 lakh to Gujarat Industrial Investment Corporation (GIIC) as full and final settlement payment towards their unsecured loan of Rs. 26.00 lakh & Rs 5 lakh paid as goodwill. 

Earlier as on January 12, 2012, the BIFR directed GIIC to accept principal amount of unsecured loan of Rs. 26.00 lakh in three equal yearly installments commencing from April 01, 2011.

Gujarat Themis Biosyn’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Guj. Themis Biosyn Share Price

390.15 -1.85 (-0.47%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×